|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1446 Duke Street |
Address2 |
|
City | Alexandria |
State | VA |
Zip Code | 22314 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 28481-12
|
||||||||
|
6. House ID# 316440000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Jennifer Popik |
Date | 7/19/2023 12:25:17 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Contacts in support of retaining all current pro-life appropriations riders and maintaining funding levels of certain riders in FY24 appropriations. Contacts in support of new riders including those related regulation of chemical abortion drugs, and others related to defunding the Department of Defense policy to pay for abortion-related travel.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CON
16. Specific lobbying issues
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. These include:
-- opposition to S.J. Res. 4 (Cardin) and H.J. Res. 25 (Pressley), resolutions purporting by multiple unconstitutional mechanisms to retroactively nullify the seven-year ratification deadline that was included in the Proposing Clause of H.J. Res. 208 of the 92nd Congress, and to declare the long-expired 1972 Equal Rights Amendment to be part of the U.S. Constitution. (Cloture failed on motion to proceed to S. J. Res. 4, 51-47, on April 27, 2023.)
-- opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional obstacles and court decisions barring resuscitation of the 1972 Equal Rights Amendment, including but not limited to opposition to schemes by certain members of Congress and others to pressure the Archivist of the United States to certify the ERA in contravention of federal court rulings.
-- support for Senate Resolution 107 (Hyde-Smith), expressing the sense of the Senate that Congress lacks power to act on a constitutional amendment resolution after submitting it to the states, or to revive an expired amendment proposal.
Contacts of advisory and informational nature regarding the nomination of Colleen Shogan, Ph.D., as Archivist of the United States (PN 68), with respect to the status of the Equal Rights Amendment, and relating to the handling of Freedom of Information Act (FOIA) requests by the National Archives and Records Administration. No position taken on confirmation. Shogan confirmed 52-45 on May 10, 2023.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page.
Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy.
Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the U.S. House issued Jan, 10, 2023.
Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions.
Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter.
Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced).
Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable.
Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind.
Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions.
Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486.
Contacts in opposition to regulation to make abortion drugs available by telemedicine.
Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present.
Contacts explaining nonsupport for the Life at Conception Act (H.R. 431) and similar legislation based on lack of clarity and erroneous legal premises.
Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced).
Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision.
Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion.
Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty.
Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions.
Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development.
Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking.
Contacts in regard to legislation (not introduced) to abortion operations on Federal lands.
Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases.
Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs.
Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others).
Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023.
Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal.
Contacts regarding strengthening guidance to providers against steering patients away from treatment.
Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market.
Contacts in support of H.485 to ban the use of QALYs to deny life-saving medical treatment on the basis of disability.
Contacts in opposition to proposed rule, Safeguarding the Rights of Conscience as Protected by Federal Statutes, 88 Fed. Reg. 820 (January 5, 2023), (RIN): 0945-AA18, Docket ID 2022-28505) as well as contacts related to various pieces of conscience legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Contacts in regard to September 9, 2022, Interim Final Rule RIN 2900-AR57 regarding providing for abortion for "health reasons" for VA healthcare beneficiaries.
Contacts in support of S.J.Res.10, a resolution of disapproval under the Congressional Review Act to block the Department of Veterans Affairs Interim Final Rule on Abortion (On this roll call vote, no. 90, on April 19, 2023, the vote failed).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Contacts in opposition to DOD memorandum, Ensuring Access to Reproductive Health Care, published on October 20, 2022 which will reimburse travel expenses relating to abortion services.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Contacts of advisory and informational nature regarding the nomination of Colleen Shogan, Ph.D., as Archivist of the United States (PN 68), including but not limited to concerns about the handling of requests under the Freedom of Information Act (FOIA) by the National Archives and Records Administration. Shogan confirmed 52-45 on May 10, 2023.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Contacts in support of proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation," 88 FR 12875 (March 1, 2023), (RIN): 1117-AB40, Docket ID DEA-407 due to impact of assisted suicide drugs.
Contacts regarding vending machine dispensing of chemical abortion drugs.
17. House(s) of Congress and Federal agencies Check if None
Drug Enforcement Administration (DEA), U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
Contacts regarding PEPFAR reauthorization over whether federal funds are going to funding recipients who also promote abortion.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |